<DOC>
	<DOCNO>NCT02547532</DOCNO>
	<brief_summary>In context increase evidence pathogenetic role microbiome COPD , aim determine total specific bacterial viral load sputum patient COPD due AATD correlate finding cellular , biochemical immunological characteristic sputa . These quantitative data obtain sputum analyzed context clinical physiological parameter patient .</brief_summary>
	<brief_title>Microbioma Sputa From COPD With Alpha-1 Antitrypsin Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>diagnosis COPD clinical stable condition , i.e . least three month last AECOPD and/or antibiotic treatment . For patient AATD condition diagnose laboratory test show low level AAT genotyping AATDrelated gene . . The presence important comorbidities ( diabetes , systemic organ infection , immunodeficiency , tumor , moderatesevere heart failure ) consider exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>COPD</keyword>
	<keyword>alpha-1 antitrypsin deficiency</keyword>
	<keyword>microbioma</keyword>
</DOC>